I agree that this site is using cookies. You can find further informations here.
X
Rahma, Osama
165  results:
Search for persons X
?
1

First-in-human phase 1 study of the arginase inhibitor INCB..:

Naing, Aung ; Papadopoulos, Kyriakos P ; Pishvaian, Michael J...
BMJ Oncology.  3 (2024)  1 - p. e000249 , 2024
Link: https://doi.org/10.1136/..
 
?
2

Efficacy, safety, and biomarker analyses of bintrafusp alfa..:

Rajan, Arun ; Abdul Sater, Houssein ; Rahma, Osama...
Journal for ImmunoTherapy of Cancer.  12 (2024)  3 - p. e008480 , 2024
Link: https://doi.org/10.1136/..
 
?
3

Ziv-aflibercept plus pembrolizumab in patients with advance..:

Baginska, Joanna ; Nau, Allison ; Gomez Diaz, Ilana...
Cancer Immunology, Immunotherapy.  73 (2024)  1 - p. , 2024
Link: https://doi.org/10.1007/..
 
?
4

First-in-human phase I study of the OX40 agonist GSK3174998..:

Postel-Vinay, Sophie ; Lam, Vincent K ; Ros, Willeke...
Journal for ImmunoTherapy of Cancer.  11 (2023)  3 - p. e005301 , 2023
Link: https://doi.org/10.1136/..
 
?
5

Tu1146 GERMLINE AND SOMATIC VARIANTS ASSOCIATED WITH IMMUNE..:

Alaiwi, Sarah Abou ; Groha, Stefan ; Gupta, Sanchit...
Gastroenterology.  164 (2023)  6 - p. S-995 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Multicenter randomized controlled trial of neoadjuvant chem..:

Katz, Matthew H G ; Petroni, Gina R ; Bauer, Todd...
Journal for ImmunoTherapy of Cancer.  11 (2023)  12 - p. e007586 , 2023
Link: https://doi.org/10.1136/..
 
?
7

Selective immune suppression using interleukin-6 receptor i..:

Fa'ak, Faisal ; Buni, Maryam ; Falohun, Adewunmi...
Journal for ImmunoTherapy of Cancer.  11 (2023)  6 - p. e006814 , 2023
Link: https://doi.org/10.1136/..
 
?
8

Incidence and Predictors of CKD and Estimated GFR Decline i..:

Chute, Donald F. ; Zhao, Sophia ; Strohbehn, Ian A....
American Journal of Kidney Diseases.  79 (2022)  1 - p. 134-137 , 2022
Link: https://doi.org/10.1053/..
 
?
9

Safety, tolerability and efficacy of agonist anti-CD27 anti..:

Sanborn, Rachel E ; Pishvaian, Michael J ; Callahan, Margaret K...
Journal for ImmunoTherapy of Cancer.  10 (2022)  8 - p. e005147 , 2022
Link: https://doi.org/10.1136/..
 
?
10

Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzu..:

Aggarwal, Charu ; Prawira, Amy ; Antonia, Scott...
Journal for ImmunoTherapy of Cancer.  10 (2022)  4 - p. e004424 , 2022
Link: https://doi.org/10.1136/..
 
?
11

Germline variants associated with toxicity to immune checkp..:

Groha, Stefan ; Alaiwi, Sarah Abou ; Xu, Wenxin...
Nature Medicine.  28 (2022)  12 - p. 2584-2591 , 2022
Link: https://doi.org/10.1038/..
 
?
12

Sotigalimab and/or nivolumab with chemotherapy in first-lin..:

Padrón, Lacey J. ; Maurer, Deena M. ; O'Hara, Mark H....
Nature Medicine.  28 (2022)  6 - p. 1167-1177 , 2022
Link: https://doi.org/10.1038/..
 
?
13

Predictors of Rheumatic Immune‐Related Adverse Events and D..:

Cunningham‐Bussel, Amy ; Wang, Jiaqi ; Prisco, Lauren C....
Arthritis & Rheumatology.  74 (2022)  3 - p. 527-540 , 2022
Link: https://doi.org/10.1002/..
 
?
14

Immune checkpoint inhibitor–induced thyroiditis is a risk f..:

Strohbehn, Ian A ; Street, Sarah ; Chute, Donald...
Nephrology Dialysis Transplantation.  37 (2021)  1 - p. 187-189 , 2021
Link: https://doi.org/10.1093/..
 
?
15

First-in-human phase I/Ib open-label dose-escalation study ..:

Piha-Paul, Sarina A ; Geva, Ravit ; Tan, Tira J...
Journal for ImmunoTherapy of Cancer.  9 (2021)  8 - p. e002863 , 2021
Link: https://doi.org/10.1136/..
 
1-15